These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38617516)

  • 1. Low expression of
    Liu X; Cui Q; Qin N
    Transl Cancer Res; 2024 Mar; 13(3):1225-1240. PubMed ID: 38617516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients.
    He JR; Li D; Zhang QX; Liu T; Ding Y; Wu CY; Chen SS; Chen JL
    Aging (Albany NY); 2023 Nov; 15(22):13265-13286. PubMed ID: 37988189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance of KLRB1 and its further association with immune cells in breast cancer.
    Xu N; Meng X; Chu H; Yang Z; Jiao Y; Li Y
    PeerJ; 2023; 11():e15654. PubMed ID: 37520246
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Xu S; Xu Y; Chai W; Liu X; Li J; Sun L; Pan H; Yan M
    J Thorac Dis; 2024 Jun; 16(6):3764-3781. PubMed ID: 38983163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GNPNAT1 is a potential biomarker correlated with immune infiltration and immunotherapy outcome in breast cancer.
    Yuan R; Zhang Y; Wang Y; Chen H; Zhang R; Hu Z; Chai C; Chen T
    Front Immunol; 2023; 14():1152678. PubMed ID: 37215111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine learning immune-related gene based on KLRB1 model for predicting the prognosis and immune cell infiltration of breast cancer.
    Huang G; Xiao S; Jiang Z; Zhou X; Chen L; Long L; Zhang S; Xu K; Chen J; Jiang B
    Front Endocrinol (Lausanne); 2023; 14():1185799. PubMed ID: 37351109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of
    Liu X; Cui Q
    Int J Gen Med; 2022; 15():8451-8465. PubMed ID: 36507250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of a novel prognostic signature based on transcription factors in breast cancer by bioinformatics analysis.
    Yang Y; Li Z; Zhong Q; Zhao L; Wang Y; Chi H
    Gland Surg; 2022 May; 11(5):892-912. PubMed ID: 35694087
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Liang C; Chen Y; Chen S; She J; Shi Q; Wang P
    Transl Cancer Res; 2023 Dec; 12(12):3641-3652. PubMed ID: 38192989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of HGH1 in breast cancer prognosis: a study on immune response and cell cycle.
    Li H; Xu Y; Xu R; Du W
    BMC Cancer; 2024 Sep; 24(1):1122. PubMed ID: 39251967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics and Experimental Analysis of the Prognostic and Predictive Value of the CHPF Gene on Breast Cancer.
    Li WW; Liu B; Dong SQ; He SQ; Liu YY; Wei SY; Mou JY; Zhang JX; Liu Z
    Front Oncol; 2022; 12():856712. PubMed ID: 35372047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches.
    Jiang J; Zhang Y; Wang J; Yang X; Ren X; Huang H; Wang J; Lu J; Zhong Y; Lin Z; Lin X; Jia Y; Lin S
    PeerJ; 2023; 11():e16166. PubMed ID: 37790630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancer RNA SLIT2 Inhibits Bone Metastasis of Breast Cancer Through Regulating P38 MAPK/c-Fos Signaling Pathway.
    Li P; Lin Z; Liu Q; Chen S; Gao X; Guo W; Gong F; Wei J; Lin H
    Front Oncol; 2021; 11():743840. PubMed ID: 34722297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer].
    Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766
    [No Abstract]   [Full Text] [Related]  

  • 15. Systematic Pan-Cancer Analysis of KLRB1 with Prognostic Value and Immunological Activity across Human Tumors.
    Cheng X; Cao Y; Wang X; Cheng L; Liu Y; Lei J; Peng W; Shi D
    J Immunol Res; 2022; 2022():5254911. PubMed ID: 35028320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic and immune significance of Rab11A in pan-cancer and its function and mechanism underlying estrogen receptor targeting in breast cancer.
    Li Y; Ding B; Wei M; Yang X; Fu R; Liu Y; Zhu L; Ding Y; Zhang W; Zhang G; Zhang S; Bu Y; He J; Deng J; Bao X; Hao J; Ma L
    Asia Pac J Clin Oncol; 2024 Oct; ():. PubMed ID: 39395024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPAR-δ as a prognostic biomarker and its association with immune infiltrates in breast cancer PPAR-δ as a prognostic biomarker and its association with immune infiltrates in breast cancer.
    Wang Z; Dong H; Li W; Han F; Zhao L
    J Cancer; 2023; 14(6):1049-1061. PubMed ID: 37151397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low KRT15 expression is associated with poor prognosis in patients with breast invasive carcinoma.
    Zhong P; Shu R; Wu H; Liu Z; Shen X; Hu Y
    Exp Ther Med; 2021 Apr; 21(4):305. PubMed ID: 33717248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of eIF4E is associated with tumor macrophage infiltration and leads to poor prognosis in breast cancer.
    Li F; Sun H; Li Y; Bai X; Dong X; Zhao N; Meng J; Sun B; Zhang D
    BMC Cancer; 2021 Dec; 21(1):1305. PubMed ID: 34876062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Analysis of the Associations of LOXL1-4 with Prognosis and Immune Infiltration in Breast Cancer.
    He L; Lin Y; Huang P; Pan H
    Altern Ther Health Med; 2024 Dec; 30(12):296-303. PubMed ID: 38518152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.